[1ST USE IN THERAPEUTICS OF A BIOLOGICAL MOLECULE WITH PSYCHOTROPIC ACTIVITY. (EXPERIMENTAL AND CLINICAL NOTE. THEORETICAL NOTES)].
D001522:Behavior, Animal; D001927:Brain Diseases; D002319:Cardiovascular System; D004569:Electroencephalography; D020915:Korsakoff Syndrome; D008660:Metabolism; D051379:Mice; D009130:Muscle, Smooth; D010600:Pharmacology; D051381:Rats; D012106:Research; D012119:Respiration; D013064:Speech Disorders; D013386:Succinates
D013386:Succinates
BEHAVIOR, ANIMAL; BRAIN DISEASES; CARDIOVASCULAR SYSTEM; ELECTROENCEPHALOGRAPHY; EXPERIMENTAL LAB STUDY; KORSAKOFF'S SYNDROME; METABOLISM; MICE; MUSCLE, SMOOTH; PHARMACOLOGY; RATS; RESPIRATION; SPEECH DISORDERS; SUCCINATES
PREMI'ERE UTILISATION EN TH'ERAPEUTIQUE D'UNE MOL'ECULE BIOLOGIQUE 'A ACTIVIT'E PSYCHOTROPE. (NOTE EXP'ERIMENTALE ET CLINIQUE. APER CUS TH'EORIQUES)